848 related articles for article (PubMed ID: 31356922)
1. Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome.
Al-Ghezi ZZ; Busbee PB; Alghetaa H; Nagarkatti PS; Nagarkatti M
Brain Behav Immun; 2019 Nov; 82():25-35. PubMed ID: 31356922
[TBL] [Abstract][Full Text] [Related]
2. Combination of Cannabinoids, Δ9- Tetrahydrocannabinol and Cannabidiol, Ameliorates Experimental Multiple Sclerosis by Suppressing Neuroinflammation Through Regulation of miRNA-Mediated Signaling Pathways.
Al-Ghezi ZZ; Miranda K; Nagarkatti M; Nagarkatti PS
Front Immunol; 2019; 10():1921. PubMed ID: 31497013
[TBL] [Abstract][Full Text] [Related]
3. Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells.
Elliott DM; Singh N; Nagarkatti M; Nagarkatti PS
Front Immunol; 2018; 9():1782. PubMed ID: 30123217
[TBL] [Abstract][Full Text] [Related]
4. A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis.
Giacoppo S; Galuppo M; Pollastro F; Grassi G; Bramanti P; Mazzon E
Daru; 2015 Oct; 23():48. PubMed ID: 26489494
[TBL] [Abstract][Full Text] [Related]
5. A Critical Review of the Role of the Cannabinoid Compounds Δ
Jones É; Vlachou S
Molecules; 2020 Oct; 25(21):. PubMed ID: 33113776
[TBL] [Abstract][Full Text] [Related]
6. CD44 deletion leading to attenuation of experimental autoimmune encephalomyelitis results from alterations in gut microbiome in mice.
Chitrala KN; Guan H; Singh NP; Busbee B; Gandy A; Mehrpouya-Bahrami P; Ganewatta MS; Tang C; Chatterjee S; Nagarkatti P; Nagarkatti M
Eur J Immunol; 2017 Jul; 47(7):1188-1199. PubMed ID: 28543188
[TBL] [Abstract][Full Text] [Related]
7. Effects of Orally Administered Cannabidiol on Neuroinflammation and Intestinal Inflammation in the Attenuation of Experimental Autoimmune Encephalomyelitis.
Dopkins N; Miranda K; Wilson K; Holloman BL; Nagarkatti P; Nagarkatti M
J Neuroimmune Pharmacol; 2022 Jun; 17(1-2):15-32. PubMed ID: 34757526
[TBL] [Abstract][Full Text] [Related]
8. Target regulation of PI3K/Akt/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis.
Giacoppo S; Pollastro F; Grassi G; Bramanti P; Mazzon E
Fitoterapia; 2017 Jan; 116():77-84. PubMed ID: 27890794
[TBL] [Abstract][Full Text] [Related]
9. The disease-modifying effects of a Sativex-like combination of phytocannabinoids in mice with experimental autoimmune encephalomyelitis are preferentially due to Δ9-tetrahydrocannabinol acting through CB1 receptors.
Moreno-Martet M; Feliú A; Espejo-Porras F; Mecha M; Carrillo-Salinas FJ; Fernández-Ruiz J; Guaza C; de Lago E
Mult Scler Relat Disord; 2015 Nov; 4(6):505-11. PubMed ID: 26590655
[TBL] [Abstract][Full Text] [Related]
10. A bidirectional association between the gut microbiota and CNS disease in a biphasic murine model of multiple sclerosis.
Colpitts SL; Kasper EJ; Keever A; Liljenberg C; Kirby T; Magori K; Kasper LH; Ochoa-Repáraz J
Gut Microbes; 2017 Nov; 8(6):561-573. PubMed ID: 28708466
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoids decrease the th17 inflammatory autoimmune phenotype.
Kozela E; Juknat A; Kaushansky N; Rimmerman N; Ben-Nun A; Vogel Z
J Neuroimmune Pharmacol; 2013 Dec; 8(5):1265-76. PubMed ID: 23892791
[TBL] [Abstract][Full Text] [Related]
12. Receptor-mediated effects of Δ
Preteroti MW; Traboulsi H; Greiss P; Lapohos O; Fonseca GJ; Eidelman DH; Baglole CJ
Immunol Cell Biol; 2023 Feb; 101(2):156-170. PubMed ID: 36510483
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoids Alleviate the LPS-Induced Cytokine Storm via Attenuating NLRP3 Inflammasome Signaling and TYK2-Mediated STAT3 Signaling Pathways In Vitro.
Suryavanshi SV; Zaiachuk M; Pryimak N; Kovalchuk I; Kovalchuk O
Cells; 2022 Apr; 11(9):. PubMed ID: 35563697
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids.
Pryce G; Riddall DR; Selwood DL; Giovannoni G; Baker D
J Neuroimmune Pharmacol; 2015 Jun; 10(2):281-92. PubMed ID: 25537576
[TBL] [Abstract][Full Text] [Related]
15. Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice.
Rahimi A; Faizi M; Talebi F; Noorbakhsh F; Kahrizi F; Naderi N
Neuroscience; 2015 Apr; 290():279-87. PubMed ID: 25637488
[TBL] [Abstract][Full Text] [Related]
16. Oxymatrine ameliorates experimental autoimmune encephalomyelitis by rebalancing the homeostasis of gut microbiota and reducing blood-brain barrier disruption.
Zhang ML; Li WX; Wang XY; Wu YL; Chen XF; Zhang H; Yang LQ; Wu CZ; Zhang SQ; Chen YL; Feng KR; Wang B; Niu L; Kong DX; Tang JF
Front Cell Infect Microbiol; 2022; 12():1095053. PubMed ID: 36710971
[TBL] [Abstract][Full Text] [Related]
17. Pomegranate peel extract ameliorates the severity of experimental autoimmune encephalomyelitis via modulation of gut microbiota.
Lu XY; Han B; Deng X; Deng SY; Zhang YY; Shen PX; Hui T; Chen RH; Li X; Zhang Y
Gut Microbes; 2020 Nov; 12(1):1857515. PubMed ID: 33382357
[TBL] [Abstract][Full Text] [Related]
18. CBD Suppression of EAE Is Correlated with Early Inhibition of Splenic IFN-γ + CD8+ T Cells and Modest Inhibition of Neuroinflammation.
Nichols JM; Kummari E; Sherman J; Yang EJ; Dhital S; Gilfeather C; Yray G; Morgan T; Kaplan BLF
J Neuroimmune Pharmacol; 2021 Jun; 16(2):346-362. PubMed ID: 32440886
[TBL] [Abstract][Full Text] [Related]
19. Constipation induced gut microbiota dysbiosis exacerbates experimental autoimmune encephalomyelitis in C57BL/6 mice.
Lin X; Liu Y; Ma L; Ma X; Shen L; Ma X; Chen Z; Chen H; Li D; Su Z; Chen X
J Transl Med; 2021 Jul; 19(1):317. PubMed ID: 34301274
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoids Delta(9)-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-kappaB and interferon-beta/STAT proinflammatory pathways in BV-2 microglial cells.
Kozela E; Pietr M; Juknat A; Rimmerman N; Levy R; Vogel Z
J Biol Chem; 2010 Jan; 285(3):1616-26. PubMed ID: 19910459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
